Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis
- 22 September 2005
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 258 (5) , 395-410
- https://doi.org/10.1111/j.1365-2796.2005.01556.x
Abstract
: Apolipoprotein (apo) B exists in two forms apoB100 and apoB48. ApoB100 is present on very low‐density lipoproteins (VLDL), intermediate density lipoproteins (IDL) and LDL. ApoB100 assembles VLDL particles in the liver. This process starts by the formation of a pre‐VLDL, which is retained in the cell unless converted to the triglyceride‐poor VLDL2. VLDL2 is secreted or converted to VLDL1 by a bulk lipidation in the Golgi apparatus. ApoB100 has a central role in the development of atherosclerosis. Two proteoglycan‐binding sequences in apoB100 have been identified, which are important for retaining the lipoprotein in the intima of the artery. Retention is essential for the development of the atherosclerotic lesion.Keywords
This publication has 118 references indexed in Scilit:
- The Triple Threat to Nascent Apolipoprotein BPublished by Elsevier ,2001
- Co-translational Interactions of Apoprotein B with the Ribosome and Translocon during Lipoprotein Assembly or Targeting to the ProteasomePublished by Elsevier ,2001
- The Amino-terminal Domain of Apolipoprotein B Does Not Undergo Retrograde Translocation from the Endoplasmic Reticulum to the CytosolPublished by Elsevier ,2000
- The ER Translocon and Retrotranslocation: Is the Shift into Reverse Manual or Automatic?Cell, 2000
- The Assembly and Secretion of Apolipoprotein B-48-containing Very Low Density Lipoproteins in McA-RH7777 CellsJournal of Biological Chemistry, 2000
- The role of the LDL receptor in apolipoprotein B secretionJournal of Clinical Investigation, 2000
- Decorin Links Low-Density Lipoproteins (LDL) to Collagen A Novel Mechanism for Retention of LDL in the Atherosclerotic PlaqueTrends in Cardiovascular Medicine, 1999
- Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDLJournal of Clinical Investigation, 1999
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987